Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 537

1.

Using State Transition Models to Explore How the Prevalence of Subtherapeutic Posaconazole Exposures Impacts the Clinical Utility of Therapeutic Drug Monitoring for Posaconazole Tablets and Oral Suspension.

Lewis RE, Kontoyiannis DP, Viale P, Sarpong EM.

Antimicrob Agents Chemother. 2019 Sep 16. pii: AAC.01435-19. doi: 10.1128/AAC.01435-19. [Epub ahead of print]

PMID:
31527039
2.

Is Candida auris here to stay? An interview with Dimitrios Kontoyiannis.

Kontoyiannis DP.

Future Microbiol. 2019 Sep;14:1083-1085. doi: 10.2217/fmb-2019-0210.

3.

Checkpoint Inhibition and Infectious Diseases: A Good Thing?

Abers MS, Lionakis MS, Kontoyiannis DP.

Trends Mol Med. 2019 Sep 4. pii: S1471-4914(19)30212-6. doi: 10.1016/j.molmed.2019.08.004. [Epub ahead of print] Review.

PMID:
31494023
4.

Therapeutic challenges of non-Aspergillus invasive mold infections in immunosuppressed patients.

Lamoth F, Kontoyiannis DP.

Antimicrob Agents Chemother. 2019 Sep 3. pii: AAC.01244-19. doi: 10.1128/AAC.01244-19. [Epub ahead of print] Review.

PMID:
31481441
5.

Gut Microbiome Signatures are Predictive of Infectious Risk Following Induction Therapy for Acute Myeloid Leukemia.

Galloway-Peña JR, Shi Y, Peterson CB, Sahasrabhojane P, Gopalakrishnan V, Brumlow CE, Daver NG, Alfayez M, Boddu PC, Khan MAW, Wargo JA, Do KA, Jenq RR, Kontoyiannis DP, Shelburne SA.

Clin Infect Dis. 2019 Aug 22. pii: ciz777. doi: 10.1093/cid/ciz777. [Epub ahead of print]

PMID:
31436833
6.

Comparative in vitro pharmacodynamic analysis of isavuconazole, voriconazole, and posaconazole against clinical isolates of aspergillosis, mucormycosis, fusariosis, and phaeohyphomycosis.

Lewis RE, Wurster S, Beyda ND, Albert ND, Kontoyiannis DP.

Diagn Microbiol Infect Dis. 2019 Jul 5:114861. doi: 10.1016/j.diagmicrobio.2019.06.013. [Epub ahead of print]

PMID:
31427139
7.

Outcomes in Invasive Pulmonary Aspergillosis Infections Complicated by Respiratory Viral Infections in Patients With Hematologic Malignancies: A Case-Control Study.

Magira EE, Chemaly RF, Jiang Y, Tarrand J, Kontoyiannis DP.

Open Forum Infect Dis. 2019 Jul 19;6(7):ofz247. doi: 10.1093/ofid/ofz247. eCollection 2019 Jul.

8.

On the Emergence of Candida auris: Climate Change, Azoles, Swamps, and Birds.

Casadevall A, Kontoyiannis DP, Robert V.

MBio. 2019 Jul 23;10(4). pii: e01397-19. doi: 10.1128/mBio.01397-19.

9.

A Novel Broad Allele-Specific TaqMan Real-Time PCR Method To Detect Triazole-Resistant Strains of Aspergillus fumigatus, Even with a Very Low Percentage of Triazole-Resistant Cells Mixed with Triazole-Susceptible Cells.

Wang Q, Kontoyiannis DP, Li R, Chen W, Bu D, Liu W.

J Clin Microbiol. 2019 Aug 26;57(9). pii: e00604-19. doi: 10.1128/JCM.00604-19. Print 2019 Sep.

PMID:
31315952
10.

Mucormycosis of the Central Nervous System.

Chikley A, Ben-Ami R, Kontoyiannis DP.

J Fungi (Basel). 2019 Jul 8;5(3). pii: E59. doi: 10.3390/jof5030059. Review.

11.

Necrotizing Mucormycosis of Wounds Following Combat Injuries, Natural Disasters, Burns, and Other Trauma.

Walsh TJ, Hospenthal DR, Petraitis V, Kontoyiannis DP.

J Fungi (Basel). 2019 Jul 4;5(3). pii: E57. doi: 10.3390/jof5030057. Review.

12.

Defining breakthrough invasive fungal infection-Position paper of the mycoses study group education and research consortium and the European Confederation of Medical Mycology.

Cornely OA, Hoenigl M, Lass-Flörl C, Chen SC, Kontoyiannis DP, Morrissey CO, Thompson GR 3rd; Mycoses Study Group Education and Research Consortium (MSG-ERC) and the European Confederation of Medical Mycology (ECMM).

Mycoses. 2019 Sep;62(9):716-729. doi: 10.1111/myc.12960. Epub 2019 Jul 19. Review.

PMID:
31254420
13.

Drosophila melanogaster as a model to study virulence and azole treatment of the emerging pathogen Candida auris.

Wurster S, Bandi A, Beyda ND, Albert ND, Raman NM, Raad II, Kontoyiannis DP.

J Antimicrob Chemother. 2019 Jul 1;74(7):1904-1910. doi: 10.1093/jac/dkz100.

PMID:
31225606
14.

Screening the in vitro susceptibility of posaconazole in clinical isolates of Candida spp. and Aspergillus spp. and analyzing the sequence of ERG11 or CYP51A in non-wild-type isolates from China.

Zhang H, Tan J, Kontoyiannis DP, Zhou Y, Liu W, Zhu P, Shi X, Wan Z, Li R, Liu W.

Diagn Microbiol Infect Dis. 2019 Oct;95(2):166-170. doi: 10.1016/j.diagmicrobio.2019.05.003. Epub 2019 May 8.

PMID:
31174994
15.

Acute acalculous cholecystitis due to Fusarium species and review of the literature on fungal cholecystitis.

Szvalb AD, Kontoyiannis DP.

Mycoses. 2019 Sep;62(9):847-853. doi: 10.1111/myc.12953. Epub 2019 Jul 1. Review.

PMID:
31166627
16.

Hurricane-Associated Mold Exposures Among Patients at Risk for Invasive Mold Infections After Hurricane Harvey - Houston, Texas, 2017.

Chow NA, Toda M, Pennington AF, Anassi E, Atmar RL, Cox-Ganser JM, Da Silva J, Garcia B, Kontoyiannis DP, Ostrosky-Zeichner L, Leining LM, McCarty J, Al Mohajer M, Murthy BP, Park JH, Schulte J, Shuford JA, Skrobarcek KA, Solomon S, Strysko J, Chiller TM, Jackson BR, Chew GL, Beer KD.

MMWR Morb Mortal Wkly Rep. 2019 May 31;68(21):469-473. doi: 10.15585/mmwr.mm6821a1.

17.

Live Monitoring and Analysis of Fungal Growth, Viability, and Mycelial Morphology Using the IncuCyte NeuroTrack Processing Module.

Wurster S, Kumaresan PR, Albert ND, Hauser PJ, Lewis RE, Kontoyiannis DP.

MBio. 2019 May 28;10(3). pii: e00673-19. doi: 10.1128/mBio.00673-19.

18.

Fecal Microbiome, Metabolites, and Stem Cell Transplant Outcomes: A Single-Center Pilot Study.

Galloway-Peña JR, Peterson CB, Malik F, Sahasrabhojane PV, Shah DP, Brumlow CE, Carlin LG, Chemaly RF, Im JS, Rondon G, Felix E, Veillon L, Lorenzi PL, Alousi AM, Jenq RR, Kontoyiannis DP, Shpall EJ, Shelburne SA, Okhuysen PC.

Open Forum Infect Dis. 2019 Apr 4;6(5):ofz173. doi: 10.1093/ofid/ofz173. eCollection 2019 May.

19.

Nitroglycerin-Citrate-Ethanol Catheter Lock Solution Is Highly Effective for In Vitro Eradication of Candida auris Biofilm.

Vargas-Cruz N, Reitzel RA, Rosenblatt J, Chaftari AM, Wilson Dib R, Hachem R, Kontoyiannis DP, Raad II.

Antimicrob Agents Chemother. 2019 Jun 24;63(7). pii: e00299-19. doi: 10.1128/AAC.00299-19. Print 2019 Jul.

PMID:
31036689
20.

Culture-Documented Invasive Mold Infections at MD Anderson Cancer Center in Houston, Texas, Pre- and Post-Hurricane Harvey.

Kontoyiannis DP, Shah EC, Wurster S, Aitken SL, Graviss L, Raad II, Chemaly RF.

Open Forum Infect Dis. 2019 Apr 2;6(4):ofz138. doi: 10.1093/ofid/ofz138. eCollection 2019 Apr.

21.

Development and internal validation of a model for predicting 60-day risk of invasive mould disease in patients with haematological malignancies.

Stanzani M, Vianelli N, Cavo M, Kontoyiannis DP, Lewis RE.

J Infect. 2019 Jun;78(6):484-490. doi: 10.1016/j.jinf.2019.04.002. Epub 2019 Apr 8.

PMID:
30974130
22.

A murine model of cutaneous aspergillosis for evaluation of biomaterials-based local delivery therapies.

Tatara AM, Watson E, Albert ND, Kontoyiannis PD, Kontoyiannis DP, Mikos AG.

J Biomed Mater Res A. 2019 Sep;107(9):1867-1874. doi: 10.1002/jbm.a.36671. Epub 2019 Apr 7.

PMID:
30882993
23.

Lack of toxicity with long term isavuconazole use in patients with hematologic malignancy.

DiPippo AJ, Kontoyiannis DP.

Clin Infect Dis. 2019 Mar 7. pii: ciz159. doi: 10.1093/cid/ciz159. [Epub ahead of print]

PMID:
30861066
24.

Serum Levels of Crushed Posaconazole Delayed-Release Tablets.

Mason MJ, McDaneld PM, Musick WL, Kontoyiannis DP.

Antimicrob Agents Chemother. 2019 Apr 25;63(5). pii: e02688-18. doi: 10.1128/AAC.02688-18. Print 2019 May. No abstract available.

PMID:
30803970
25.

Corrigendum: Azole-Resistance in Aspergillus terreus and Related Species: An Emerging Problem or a Rare Phenomenon?

Zoran T, Sartori B, Sappl L, Aigner M, Sánchez-Reus F, Rezusta A, Chowdhary A, Taj-Aldeen SJ, Arendrup MC, Oliveri S, Kontoyiannis DP, Alastruey-Izquierdo A, Lagrou K, Lo Cascio G, Meis JF, Buzina W, Farina C, Drogari-Apiranthitou M, Grancini A, Tortorano AM, Willinger B, Hamprecht A, Johnson E, Klingspor L, Arsic-Arsenijevic V, Cornely OA, Meletiadis J, Prammer W, Tullio V, Vehreschild JJ, Trovato L, Lewis RE, Segal E, Rath PM, Hamal P, Rodriguez-Iglesias M, Roilides E, Arikan-Akdagli S, Chakrabarti A, Colombo AL, Fernández MS, Martin-Gomez MT, Badali H, Petrikkos G, Klimko N, Heimann SM, Uzun O, Roudbary M, de la Fuente S, Houbraken J, Risslegger B, Sabino R, Lass-Flörl C, Lackner M.

Front Microbiol. 2019 Jan 14;9:3245. doi: 10.3389/fmicb.2018.03245. eCollection 2018.

26.

Myeloid malignancies with somatic GATA2 mutations can be associated with an immunodeficiency phenotype.

Alfayez M, Wang SA, Bannon SA, Kontoyiannis DP, Kornblau SM, Orange JS, Mace EM, DiNardo CD.

Leuk Lymphoma. 2019 Aug;60(8):2025-2033. doi: 10.1080/10428194.2018.1551535. Epub 2019 Jan 16.

PMID:
30648453
27.

Rhodotorula infection in haematological patient: Risk factors and outcome.

Potenza L, Chitasombat MN, Klimko N, Bettelli F, Dragonetti G, Del Principe MI, Nucci M, Busca A, Fracchiolla N, Sciumè M, Spolzino A, Delia M, Mancini V, Nadali GP, Dargenio M, Shadrivova O, Bacchelli F, Aversa F, Sanguinetti M, Luppi M, Kontoyiannis DP, Pagano L.

Mycoses. 2019 Mar;62(3):223-229. doi: 10.1111/myc.12875. Epub 2018 Dec 28.

PMID:
30525252
28.

Author Correction: Iron restriction inside macrophages regulates pulmonary host defense against Rhizopus species.

Andrianaki AM, Kyrmizi I, Thanopoulou K, Baldin C, Drakos E, Soliman SSM, Shetty AC, McCracken C, Akoumianaki T, Stylianou K, Ioannou P, Pontikoglou C, Papadaki HA, Tzardi M, Belle V, Etienne E, Beauvais A, Samonis G, Kontoyiannis DP, Andreakos E, Bruno VM, Ibrahim AS, Chamilos G.

Nat Commun. 2018 Nov 22;9(1):5015. doi: 10.1038/s41467-018-07301-y.

29.

Preexposure to Isavuconazole Increases the Virulence of Mucorales but Not Aspergillus fumigatus in a Drosophila melanogaster Infection Model.

Wurster S, Lewis RE, Albert ND, Kontoyiannis DP.

Antimicrob Agents Chemother. 2019 Jan 29;63(2). pii: e01896-18. doi: 10.1128/AAC.01896-18. Print 2019 Feb.

30.
31.

Nivolumab-induced encephalitis post allogeneic stem cell transplant in a patient with Hodgkin's disease.

De la Hoz A, Foolad F, Gallegos C, Kornblau S, Kontoyiannis DP.

Bone Marrow Transplant. 2019 May;54(5):749-751. doi: 10.1038/s41409-018-0363-6. Epub 2018 Oct 15. No abstract available.

PMID:
30323308
32.

Invasive fungal disease and cytomegalovirus infection: is there an association?

Yong MK, Slavin MA, Kontoyiannis DP.

Curr Opin Infect Dis. 2018 Dec;31(6):481-489. doi: 10.1097/QCO.0000000000000502.

PMID:
30299361
33.

Tolerability of isavuconazole after posaconazole toxicity in leukaemia patients.

DiPippo AJ, Rausch CR, Kontoyiannis DP.

Mycoses. 2019 Jan;62(1):81-86. doi: 10.1111/myc.12851. Epub 2018 Oct 24.

PMID:
30230043
34.

Recent advances in the molecular diagnosis of mucormycosis.

Dadwal SS, Kontoyiannis DP.

Expert Rev Mol Diagn. 2018 Oct;18(10):845-854. doi: 10.1080/14737159.2018.1522250. Epub 2018 Sep 19. Review.

PMID:
30203997
35.

Immunosuppressed Adult Zebrafish Model of Mucormycosis.

Tatara AM, Wurster S, Lockworth CR, Albert ND, Walsh TJ, Mikos AG, Eisenhoffer GT, Kontoyiannis DP.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e00698-18. doi: 10.1128/AAC.00698-18. Print 2018 Nov. No abstract available.

36.

Patient-reported fatigue prior to treatment is prognostic of survival in patients with acute myeloid leukemia.

Lacourt TE, Kavelaars A, Ohanian M, Shah ND, Shelburne SA, Futreal A, Kontoyiannis DP, Heijnen CJ.

Oncotarget. 2018 Jul 27;9(58):31244-31252. doi: 10.18632/oncotarget.25787. eCollection 2018 Jul 27.

37.

Iron restriction inside macrophages regulates pulmonary host defense against Rhizopus species.

Andrianaki AM, Kyrmizi I, Thanopoulou K, Baldin C, Drakos E, Soliman SSM, Shetty AC, McCracken C, Akoumianaki T, Stylianou K, Ioannou P, Pontikoglou C, Papadaki HA, Tzardi M, Belle V, Etienne E, Beauvais A, Samonis G, Kontoyiannis DP, Andreakos E, Bruno VM, Ibrahim AS, Chamilos G.

Nat Commun. 2018 Aug 20;9(1):3333. doi: 10.1038/s41467-018-05820-2. Erratum in: Nat Commun. 2018 Nov 22;9(1):5015.

38.

Therapy of Mucormycosis.

Sipsas NV, Gamaletsou MN, Anastasopoulou A, Kontoyiannis DP.

J Fungi (Basel). 2018 Jul 31;4(3). pii: E90. doi: 10.3390/jof4030090. Review.

39.

A New Method for Reactivating and Expanding T Cells Specific for Rhizopus oryzae.

Castillo P, Wright KE, Kontoyiannis DP, Walsh T, Patel S, Chorvinsky E, Bose S, Hazrat Y, Omer B, Albert N, Leen AM, Rooney CM, Bollard CM, Cruz CRY.

Mol Ther Methods Clin Dev. 2018 Mar 14;9:305-312. doi: 10.1016/j.omtm.2018.03.003. eCollection 2018 Jun 15.

40.

Bronchoalveolar Lavage Fluid Cytology in Culture-Documented Invasive Pulmonary Aspergillosis in Patients with Hematologic Diseases: Analysis of 67 Episodes.

Fernández-Cruz A, Magira E, Heo ST, Evans S, Tarrand J, Kontoyiannis DP.

J Clin Microbiol. 2018 Sep 25;56(10). pii: e00962-18. doi: 10.1128/JCM.00962-18. Print 2018 Oct.

41.

Mixed mold pulmonary infections in haematological cancer patients in a tertiary care cancer centre.

Magira EE, Jiang Y, Economides M, Tarrand J, Kontoyiannis DP.

Mycoses. 2018 Nov;61(11):861-867. doi: 10.1111/myc.12830. Epub 2018 Aug 1.

PMID:
30015364
42.

Cytomegalovirus reactivation can be a cause of DAT-negative hemolytic anemia in patients with chronic lymphocytic leukemia.

Strati P, Gabutti C, Thompson PA, Kontoyiannis DP, Ferrajoli A.

Leuk Lymphoma. 2019 Feb;60(2):535-537. doi: 10.1080/10428194.2018.1474527. Epub 2018 Jun 18. No abstract available.

PMID:
29911929
43.

Breakthrough Invasive Mold Infections in the Hematology Patient: Current Concepts and Future Directions.

Lionakis MS, Lewis RE, Kontoyiannis DP.

Clin Infect Dis. 2018 Oct 30;67(10):1621-1630. doi: 10.1093/cid/ciy473.

PMID:
29860307
44.

Calcium sequestration by fungal melanin inhibits calcium-calmodulin signalling to prevent LC3-associated phagocytosis.

Kyrmizi I, Ferreira H, Carvalho A, Figueroa JAL, Zarmpas P, Cunha C, Akoumianaki T, Stylianou K, Deepe GS Jr, Samonis G, Lacerda JF, Campos A Jr, Kontoyiannis DP, Mihalopoulos N, Kwon-Chung KJ, El-Benna J, Valsecchi I, Beauvais A, Brakhage AA, Neves NM, Latge JP, Chamilos G.

Nat Microbiol. 2018 Jul;3(7):791-803. doi: 10.1038/s41564-018-0167-x. Epub 2018 May 30.

PMID:
29849062
45.

Breakthrough Fungal Infections in Patients With Leukemia Receiving Isavuconazole.

Rausch CR, DiPippo AJ, Bose P, Kontoyiannis DP.

Clin Infect Dis. 2018 Oct 30;67(10):1610-1613. doi: 10.1093/cid/ciy406.

46.

How to prophylax against invasive fungal infections in adult ALL? An unmet need.

Cornely OA, Kontoyiannis DP.

Mycoses. 2018 Sep;61(9):646-649. doi: 10.1111/myc.12786. Epub 2018 Jun 13.

PMID:
29693737
47.

Azole-Resistance in Aspergillus terreus and Related Species: An Emerging Problem or a Rare Phenomenon?

Zoran T, Sartori B, Sappl L, Aigner M, Sánchez-Reus F, Rezusta A, Chowdhary A, Taj-Aldeen SJ, Arendrup MC, Oliveri S, Kontoyiannis DP, Alastruey-Izquierdo A, Lagrou K, Cascio GL, Meis JF, Buzina W, Farina C, Drogari-Apiranthitou M, Grancini A, Tortorano AM, Willinger B, Hamprecht A, Johnson E, Klingspor L, Arsic-Arsenijevic V, Cornely OA, Meletiadis J, Prammer W, Tullio V, Vehreschild JJ, Trovato L, Lewis RE, Segal E, Rath PM, Hamal P, Rodriguez-Iglesias M, Roilides E, Arikan-Akdagli S, Chakrabarti A, Colombo AL, Fernández MS, Martin-Gomez MT, Badali H, Petrikkos G, Klimko N, Heimann SM, Uzun O, Roudbary M, de la Fuente S, Houbraken J, Risslegger B, Lass-Flörl C, Lackner M.

Front Microbiol. 2018 Mar 28;9:516. doi: 10.3389/fmicb.2018.00516. eCollection 2018. Erratum in: Front Microbiol. 2019 Jan 14;9:3245.

48.

Prolonged voriconazole treatment in a patient with chronic lymphocytic leukemia resulting in a litany of chronic overlapping toxicities.

Rausch CR, Kontoyiannis DP.

J Oncol Pharm Pract. 2019 Apr;25(3):747-753. doi: 10.1177/1078155218762624. Epub 2018 Mar 19.

PMID:
29554829
49.

Advances in the diagnosis and treatment of fungal infections of the CNS.

Schwartz S, Kontoyiannis DP, Harrison T, Ruhnke M.

Lancet Neurol. 2018 Apr;17(4):362-372. doi: 10.1016/S1474-4422(18)30030-9. Epub 2018 Feb 21. Review.

PMID:
29477506
50.

Detecting Infections Rapidly and Easily for Candidemia Trial, Part 2 (DIRECT2): A Prospective, Multicenter Study of the T2Candida Panel.

Clancy CJ, Pappas PG, Vazquez J, Judson MA, Kontoyiannis DP, Thompson GR 3rd, Garey KW, Reboli A, Greenberg RN, Apewokin S, Lyon GM 3rd, Ostrosky-Zeichner L, Wu AHB, Tobin E, Nguyen MH, Caliendo AM.

Clin Infect Dis. 2018 May 17;66(11):1678-1686. doi: 10.1093/cid/cix1095.

PMID:
29438475

Supplemental Content

Loading ...
Support Center